Signify Health, Inc. (SGFY) Tops Q4 EPS by 10c, Offers Guidance

Signify Health, Inc. (NYSE: SGFY) reported Q4 EPS of $0.13, $0.10 better than the analyst estimate of $0.03. Revenue for the quarter came in at $181.4 million versus the consensus estimate of $173.15 million.

GUIDANCE:

Signify Health, Inc. sees FY2022 revenue of $948-971 million, versus the consensus of $928.2 million.

• Total GAAP revenue in the range of $948 million to $971 million; and
• Total adjusted EBITDA1 in the range of $212 million to $222 million.

For earnings history and earnings-related data on Signify Health, Inc. (SGFY) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says